New indenopyrazole linked oxadiazole conjugates as anti-pancreatic cancer agents: Design, synthesis, in silico studies including 3D-QSAR analysis.

Bioorg Med Chem Lett

Organic Synthesis and Process Chemistry Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500007, India; Academy of Scientific and Innovative Research, Ghaziabad 201002, India; School of Pharmaceutical Education and Research (SPER), Jamia Hamdard, New Delhi 110062, India. Electronic address:

Published: July 2021

To continue the quest of newer anticancer agents, herein a novel class of 1,4-Dihydroindenopyrazole linked oxadiazole conjugates 9(a-r) was designed, synthesized and experimented for their anti-proliferative activities against four different cancer cell lines (human) such as MDA MB-231 (breast), PANC-1 (pancreatic), MCF-7 (breast), and Caco-2 (Colorectal) by using MTT assay. Among the series compound 9h and 9 m demonstrated significant potency against the PANC-1 (human pancreatic cancer cells) with IC value 7.4 μM and 4.3 μM respectively. While compound 9 m was found to be equipotent to standard Gomitabine (IC = 4.2 μM). The detailed biological assays revealed S phase cell cycle arrest and their ability to propagate apoptosis by activating caspase 3 and 9 enzymes which was confirmed by Annexin-FITC assay and caspase assay. Moreover, docking study suggested their binding modes and interactions with caspase-3. In addition, in silico studies revealed that they exhibit good pharmacokinetics and drug likeliness properties. Furthermore, 3D-QSAR was carried out to achieve a pharmacophoric model with CoMFA (q = 0.631, r = 0.977) and CoMSIA (q = 0.686, r = 0.954) on PANC-1 cancer cells which were established, generated and validated to be reliable models for further design and optimization of newer molecules with enhanced anticancer activity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2021.128094DOI Listing

Publication Analysis

Top Keywords

linked oxadiazole
8
oxadiazole conjugates
8
silico studies
8
compound 9 m
8
cancer cells
8
indenopyrazole linked
4
conjugates anti-pancreatic
4
cancer
4
anti-pancreatic cancer
4
cancer agents
4

Similar Publications

Objective: Duchenne muscular dystrophy (DMD) is a rare X-linked neurodegenerative disorder caused by mutations in the gene. This study examined the efficacy and safety of ataluren, the first oral treatment for DMD with nonsense mutations (nmDMD), in patients in the Middle East.

Methods: This retrospective longitudinal study assessed the outcomes of seven boys with nmDMD who received treatment with ataluren and follow-up at a single center since 2016.

View Article and Find Full Text PDF

Synthesis, Characterizations, Anti-Diabetic and Molecular Modeling Approaches of Hybrid Indole-Oxadiazole Linked Thiazolidinone Derivatives.

Pharmaceuticals (Basel)

October 2024

Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.

Article Synopsis
  • The research focuses on creating hybrid compounds that combine indole and oxadiazole to develop new, effective anti-diabetic agents.
  • A total of 15 compounds were synthesized, and their structures were characterized using C-NMR, H-NMR, and HREI-MS techniques, with their activity against diabetic enzymes α-amylase and α-glucosidase tested.
  • The most promising compound, a fluoro-substituted analog, showed significantly better inhibition than the standard drug acarbose, highlighting the potential of these compounds for future diabetes treatments.
View Article and Find Full Text PDF

Olefin-linked covalent organic frameworks (OL-COFs) show great promise for visible-light-driven photocatalysis. Manipulating atomic-level donor-acceptor interactions in OL-COFs is key to understanding their exciton effects in this system. Here, three OL-COFs are presented with orthorhombic lattice structures, synthesized via Knoevenagel polycondensation reaction of terephthalaldehyde and tetratopic monomers featuring phenyl, benzo[c][1,2,5]oxadiazole, and benzo[c][1,2,5]thiadiazole moieties.

View Article and Find Full Text PDF

Bacterial tyrosinases and their inhibitors.

Enzymes

September 2024

Department of NEUROFARBA-Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Sesto Fiorentino, Florence, Italy. Electronic address:

Article Synopsis
  • Bacterial tyrosinase is a copper-containing enzyme found in various bacteria like actinobacteria and proteobacteria, crucial for melanin production and enzymatic browning, making it useful in coloring and food processing.
  • Its unique substrate specificity allows for the development of biosensors that detect phenolic compounds and provides potential alternatives to mushroom tyrosinase for various applications.
  • Medicinal scientists are studying bacterial tyrosinase inhibitors, particularly heterocyclic compounds, to combat challenges like antibiotic resistance, skin cancer, and the browning of fruits and vegetables.
View Article and Find Full Text PDF

Structural Rheology in the Development and Study of Complex Polymer Materials.

Polymers (Basel)

August 2024

A.V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences, 29 Leninsky Prospect, 119991 Moscow, Russia.

The progress in polymer science and nanotechnology yields new colloidal and macromolecular objects and their combinations, which can be defined as complex polymer materials. The complexity may include a complicated composition and architecture of macromolecular chains, specific intermolecular interactions, an unusual phase behavior, and a structure of a multi-component polymer-containing material. Determination of a relation between the structure of a complex material, the structure and properties of its constituent elements, and the rheological properties of the material as a whole is the subject of structural rheology-a valuable tool for the development and study of novel materials.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!